75 posts categorized in

Research

  

Dr. John Andraos’s ’19 Journey in Pharmacy Education

April 30, 2024 by | Pharmacy

Since graduating with his Doctor of Pharmacy in 2019, Dr. John Andraos has merged his passions for teaching and patient care. Currently serving as an Assistant Professor at Western University College of Pharmacy, Dr. Andraos was part of the inaugural APEx program before bridging into CUSP for his Doctor of Pharmacy degree. Dr. Andraos initially

CPhA Honors CUSP Faculty and Students at Western Pharmacy Exchange

April 26, 2024 by | Research

Chapman University students, faculty, and alumni turned up in record numbers at the 2024 Western Pharmacy Exchange, hosted by the California Pharmacists Association (CPhA) in Las Vegas from April 19-21. CPhA honored Dr. Laressa Bethishou with the 2024 New Practitioner Award, which recognizes an outstanding new practitioner who has demonstrated leadership at multiple levels of

BPS Paper of the Year Awarded to Dr. Sumbria

April 23, 2024 by | Research

The Department of Biomedical and Pharmaceutical Sciences (BPS) has awarded Dr. Rachita Sumbria  the 2023 BPS Paper of the Year Award. Dr. Sumbria recognition is based on her publication, “Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.“ Dr. Sumbria’s groundbreaking research, conducted in collaboration with a

Dean Ostrom Provides Expertise for Verywell Health

April 19, 2024 by | Pharmacy News

Dean Ren Ostrom recently provided his expertise in Verywell Health, a publication that reaches over 300 million readers annually. Dr. Ostrom discussed at length the implications of a recent study published in the New England Journal of Medicine regarding the necessity of beta-blockers for heart attack patients with preserved heart function. Dr. Ostrom emphasized the

NIH Awards Dr. Zhang $434K for Rare Genetic Disease Research

April 16, 2024 by | Research

Dr. Miao Zhang has been awarded a prestigious grant totaling $434,024 by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). This funding will support Dr. Zhang’s groundbreaking project “Channelopathy of KCa2.3 and Zimmermann-Laband syndrome,” aimed at unraveling the complexities surrounding Zimmermann-Laband syndrome 3 (ZLS3). Zimmermann-Laband syndrome 3

On the CUSP: March 2024

April 5, 2024 by | Research

Publications Dr. Ren Ostrom, Dr. Isabella Cattani-Cavalieri, Dr. Francisco Nuñez, Jordyn Margolis,  and PhD candidate Camelia Anicolaesei published Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ in JoVE Journal Dr. Rachita Sumbria, Dr. Nataraj Jagadeesan, Dr. Devaraj Chandrashekar, and Chuli Roules worked with others on “Modulation of hippocampal protein expression

Elyn Lam Awarded ASHP Student Leadership Award

April 5, 2024 by | Pharmacy

Elyn Lam has recently been awarded with the ASHP Student Leadership Award by the American Society of Health-System Pharmacists (ASHP). Set to graduate as a Doctor of Pharmacy in May, Elyn has been chosen as a recipient of this highly prestigious award from a pool of exceptionally qualified applicants from across the nation. She stood

Dr. Cintia Citterio Receives Endocrine Society Early Investigator Award

February 20, 2024 by | Pharmacy

Dr. Cintia Citterio has been honored with the Endocrine Society Early Investigator Award, awarding her outstanding contributions to hormone-related research. Selected as one of five awardees nationwide, this recognition places her among the top emerging researchers for her role in addressing and advancing our understanding of hormone-related conditions. The Early Investigator Award supports the development

CUSP Advances in Genetic Editing with CRISPR Technology

February 14, 2024 by | Research

Offering new prospects for medical inventions, Chapman University School of Pharmacy researchers continue to make strides in gene editing. The recent study “Modifying peptide/lipid-associated nucleic acids (PLANAs) for CRISPR/Cas9 ribonucleoprotein delivery” centers around the manipulation of genetic material through the CRISPR technology, a technology that has regained momentum since initial reports in 2005. The authors, including faculty

Log In
Open Main Menu